InvestorsHub Logo
Followers 467
Posts 26918
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 286

Tuesday, 06/19/2012 9:39:08 AM

Tuesday, June 19, 2012 9:39:08 AM

Post# of 358
8:28AM On The Wires (WIRES) : Depomed (DEPO) has received a notice of allowance from the USPTO for a patent application further expanding the patent portfolio around Gralise (gabapentin), the co's once-daily product for the management of postherpetic neuralgia. The allowed patent claims include claims related to gabapentin matrix dosage forms that release gabapentin to the upper gastrointestinal tract over five to 12 hours and are characterized by specific pharmacokinetic parameters.